CONTEXT THERAPEUTICS INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
CONTEXT THERAPEUTICS INC. (CNTX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $760.10 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2026-03-23
- CONTEXT THERAPEUTICS INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2025 was $760.10K, a 42.40% increase from fiscal 2024.
- CONTEXT THERAPEUTICS INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2024 was $533.78K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month |
|---|---|
| 2025-12-31 | $760.10K 10-K · filed 2026-03-23 |
| 2024-12-31 | $533.78K 10-K · filed 2026-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |